# 2025年12月2日 - 专业文献速递

本期速递为您整理了最新的科研文献及AI评价，每一篇文献都包含了详细的元数据、原文摘要、中文翻译和AI的专业点评，敬请参考。

---

## 1. 基于整合组学数据分析指导的常见癫痫遗传风险因素识别

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41319129](https://pubmed.ncbi.nlm.nih.gov/41319129)
**期刊：** Epilepsia
**PMID：** 41319129
**DOI：** 10.1111/epi.70021

### 第一部分 原文与翻译

**英文原标题：** Genetic risk factor identification for common epilepsies guided by integrative omics data analysis.

**英文摘要原文：**
OBJECTIVE: Genetic generalized epilepsies (GGEs) comprise the most common genetically determined epilepsy syndromes, following a complex mode of inheritance. Although many important common and rare genetic factors causing or contributing to these epilepsies have been identified in the past decades, many features of the genetic architecture are still insufficiently understood. This study integrates genome-wide association study (GWAS) data from the International League Against Epilepsy Consortium on Complex Epilepsies with transcriptome-wide association studies to identify genes whose genetically regulated expression levels are associated with epilepsy.

METHODS: To achieve this, we used multiple computational approaches, including MAGMA, a tool for gene analysis of GWAS data, and its derivatives E-MAGMA and H-MAGMA, to improve gene mapping accuracy by utilizing tissue-specific expression and chromatin interaction data. Furthermore, we developed ME-MAGMA to incorporate methylation quantitative trait loci data, providing insights into epigenetic factors.

RESULTS: We identified a total of 897 false discovery rate-corrected (<.05) candidates. These include voltage-gated calcium channels, voltage-gated potassium channels, and other genes such as NPRL2, CACNB2, and KCNT1 associated with epilepsy pathogenesis that act as key players in neuronal communication and signaling in the brain.

SIGNIFICANCE: In this study, we propose new candidate genes to expand the dataset of potential epilepsy-causing genes. Further research on these genes may enhance our understanding of the complex regulatory mechanisms underlying GGE and other types of epilepsy, potentially revealing targets for therapeutic intervention.

**中文摘要译文：**
目的：遗传性全面性癫痫（GGE）是最常见的遗传决定的癫痫综合征，遵循复杂的遗传模式。虽然在过去几十年中已经识别出许多导致或促进这些癫痫的重要常见和罕见遗传因素，但遗传结构的许多特征仍未被充分理解。本研究将来自国际抗癫痫联盟复杂性癫痫联盟的全基因组关联研究（GWAS）数据与转录组全关联研究相结合，以识别其遗传调节表达水平与癫痫相关的基因。

方法：为实现这一目标，我们使用了多种计算方法，包括用于GWAS数据基因分析的MAGMA工具及其衍生工具E-MAGMA和H-MAGMA，通过利用组织特异性表达和染色质相互作用数据来提高基因映射准确性。此外，我们开发了ME-MAGMA以纳入甲基化数量性状位点数据，为表观遗传因素提供见解。

结果：我们总共识别出897个经过错误发现率校正（<.05）的候选基因。这些包括电压门控钙通道、电压门控钾通道以及其他与癫痫发病机制相关的基因，如NPRL2、CACNB2和KCNT1，这些基因在大脑神经元通讯和信号传导中充当关键角色。

意义：在本研究中，我们提出了新的候选基因以扩展潜在致癫痫基因数据集。对这些基因的进一步研究可能会增强我们对GGE和其他类型癫痫复杂调控机制的理解，可能揭示治疗干预的靶点。

### 第二部分 AI 大师评价

本研究通过整合GWAS与转录组关联研究，采用创新的计算生物学方法（包括E-MAGMA、H-MAGMA和ME-MAGMA）系统性地识别了897个与常见癫痫相关的候选基因，为理解遗传性全面性癫痫的复杂遗传结构提供了重要见解。研究发现了多个关键的离子通道基因（如电压门控钙、钾通道）和神经信号传导相关基因，这些发现不仅扩展了癫痫致病基因库，更为精准医疗和个体化治疗提供了新的潜在靶点。虽然本研究在方法学上具有显著创新性，但需要进一步的功能验证研究来确认这些候选基因的致病机制，这代表了未来癫痫遗传研究的重要方向。

---

## 2. 我们对迷走神经刺激后的发作减少是否达成一致？来自CONNECTiVOS数据库的回顾性和前瞻性发作频率评估的评分者间信度研究。

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41319125](https://pubmed.ncbi.nlm.nih.gov/41319125)
**期刊：** Epilepsia
**PMID：** 41319125
**DOI：** 10.1111/epi.70031

### 第一部分 原文与翻译

**英文原标题：** Do we agree on seizure reduction after vagus nerve stimulation? Interrater reliability of retrospective and prospective seizure frequency ratings from the CONNECTiVOS database.

**英文摘要原文：**
OBJECTIVE: Although vagus nerve stimulation (VNS) is a well-established neuromodulation therapy for drug-resistant epilepsy, treatment outcomes remain heterogeneous. One possible source of variability lies in differing interpretations of seizure frequency ratings (SFRs). This study examined interrater reliability (IRR) in SFRs between (1) retrospective clinician-clinician chart reviews and (2) prospective caregiver-clinician reports, and explored sources of disagreement.

METHODS: Data were collected from the CONNECTiVOS database. In the retrospective cohort (n = 254), two clinicians independently reviewed medical records and rated seizure frequency across multiple timepoints. In the prospective cohort (n = 214), caregivers and clinicians independently reported SFR in children treated with VNS. IRR was assessed across different measurement thresholds, and potential causes of disagreement were analyzed.

RESULTS: Clinician-clinician agreement in retrospective chart reviews was excellent (intraclass correlation coefficient [ICC] > .90, Cohen κ > .80), with 18.8% divergent ratings and 4.8% exceeding the reliable change index. Disagreement was significantly associated with higher mean seizure frequency at baseline (p = .004) and at postoperative timepoints (p < .001). In the prospective caregiver-clinician comparison, agreement for absolute seizure frequency was poor (ICC < .50), with discrepancies in 86.5% of cases, although only 1.8% were statistically significant. When rating pairs diverged, clinicians more often reported lower absolute seizure frequencies (p = .002) and greater relative seizure reductions (p = .023) and were more likely to classify patients as achieving a 90% reduction (p = .043).

SIGNIFICANCE: This study highlights interrater variability in both retrospective and prospective SFR assessments, a finding systematically related to baseline seizure frequency. Coarser classifications (e.g., 50% or 90% seizure reduction) may improve agreement but reduce clinical nuance. Future efforts should focus on structured, patient-centered documentation and the development of objective outcome measures in VNS evaluation, particularly for children with high seizure burden.

**中文摘要译文：**
目标：虽然迷走神经刺激（VNS）是药物难治性癫痫的成熟神经调节治疗，但治疗效果仍然存在异质性。变异性的一个可能来源在于对发作频率评估（SFRs）的不同解释。本研究检查了（1）回顾性临床医生-临床医生图表审查和（2）前瞻性照护者-临床医生报告之间SFRs的评分者间信度（IRR），并探讨了分歧的来源。

方法：数据收集自CONNECTiVOS数据库。在回顾性队列（n = 254）中，两名临床医生独立审查医疗记录并在多个时间点评估发作频率。在前瞻性队列（n = 214）中，照护者和临床医生独立报告接受VNS治疗的儿童的SFR。在不同测量阈值下评估IRR，并分析分歧的潜在原因。

结果：回顾性图表审查中的临床医生-临床医生一致性极好（组内相关系数[ICC] > .90，Cohen κ > .80），18.8%的评估存在分歧，4.8%超过可靠变化指数。分歧与基线时较高的平均发作频率（p = .004）和术后时间点的发作频率（p < .001）显著相关。在前瞻性照护者-临床医生比较中，绝对发作频率的一致性较差（ICC < .50），86.5%的病例存在差异，尽管只有1.8%具有统计学显著性。当评估对出现分歧时，临床医生更常报告较低的绝对发作频率（p = .002）和较大的相对发作减少（p = .023），并且更有可能将患者分类为达到90%减少（p = .043）。

意义：本研究突出了回顾性和前瞻性SFR评估中的评分者间变异性，这一发现与基线发作频率系统相关。较粗的分类（如50%或90%发作减少）可能提高一致性但降低临床细微差别。未来的努力应集中在结构化、以患者为中心的文档记录和VNS评估中客观结局指标的开发，特别是对于高发作负担的儿童。

### 第二部分 AI 大师评价

本研究旨在评估VNS治疗后发作减少评估的评分者间一致性，具有重要的临床意义。研究采用回顾性和前瞻性双重设计，利用CONNECTiVOS数据库分析临床医生间以及照护者与临床医生间的评估差异，方法学严谨。关键发现显示临床医生间一致性良好，但照护者与临床医生间存在显著差异，特别是高发作频率患者中分歧更大，揭示了当前评估体系的主观性局限。研究的创新性在于系统性地量化了评估变异性，为改进VNS疗效评价提供了实证依据，对标准化癫痫治疗评估具有重要价值。然而，研究未能深入探讨文化背景、医疗环境等影响评估的主观因素，未来需要结合更多客观监测指标来完善评估体系。

---

## 3. 1990-2023年头痛疾病的全球、区域和国家负担：2023年全球疾病负担研究的系统分析

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/41240916](https://pubmed.ncbi.nlm.nih.gov/41240916)
**期刊：** The Lancet. Neurology
**PMID：** 41240916
**DOI：** 10.1016/S1474-4422(25)00402-8

### 第一部分 原文与翻译

**英文原标题：** Global, regional, and national burden of headache disorders, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.

**英文摘要原文：**
BACKGROUND: The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2023 estimates health loss from migraine, tension-type headache, and medication-overuse headache. This study presents updated results on headache-attributed burden from 1990 to 2023, along with clinical and public health implications.

METHODS: Data on the prevalence, incidence, or remission of migraine, tension-type headache, and medication-overuse headache were extracted from published population-based studies. We used hierarchical Bayesian meta-regression modelling to estimate global, regional, and country-level prevalence of headache disorders. For the first time in GBD 2023, age-specific and sex-specific estimates of time in symptomatic state were applied by meta-analysing individual participant data from 41 653 individuals from the general populations of 18 countries from all parts of the world. Disability weights were applied to calculate years lived with disability (YLDs). Since medication-overuse headache is a sequela of a mistreated primary headache (due to medication overuse), its burden was reattributed to migraine or tension-type headache, informed by a meta-analysis of three longitudinal studies.

FINDINGS: In 2023, 2 9 billion individuals (95% uncertainty interval 2 6-3 1) were affected by headache disorders, with a global age-standardised prevalence of 34 6% (31 6-37 5) and a YLD rate of 541 9 (373 4-739 9) per 100 000 population, with 487 5 (323 0-678 8) per 100 000 population attributed to migraine. The prevalence rates of these headache disorders have remained stable over the past three decades. YLD rates due to headache disorders were more than twice as high in females (739 9 [511 2-1011 5] per 100 000) as in males (346 1 [240 4-481 8] per 100 000). Medication-overuse headache contributed 58 9% of the YLD estimates for tension-type headache in males and 56 1% in females, as well as 22 6% of the YLD estimates for migraines in males and 14 1% in females.

INTERPRETATION: Headache disorders, in particular migraine, continue to be a major global health challenge, emphasising the need for effective management and prevention strategies. Much headache-attributed burden could be averted or eliminated by avoiding overuse of medication (including over-the-counter medication), underscoring the importance of public education.

FUNDING: Gates Foundation.

**中文摘要译文：**
背景：全球疾病、伤害和危险因素研究（GBD）2023年估算了偏头痛、紧张型头痛和药物过度使用性头痛导致的健康损失。本研究呈现了1990年至2023年头痛所致负担的更新结果，以及临床和公共卫生意义。

方法：从已发表的人群基础研究中提取偏头痛、紧张型头痛和药物过度使用性头痛的患病率、发病率或缓解率数据。我们使用分层贝叶斯元回归模型来估算头痛疾病的全球、区域和国家层面患病率。在GBD 2023年中首次应用了通过对来自全球18个国家的普通人群41653名个体参与者数据进行荐莫分析得出的年龄特异性和性别特异性的症状状态时间估计。应用残疾权重计算残疾生存年（YLDs）。由于药物过度使用性头痛是治疗不当的原发性头痛（因药物过度使用）的后果，其负担被重新归因于偏头痛或紧张型头痛，这一做法由三项纵向研究的荐莫分析提供支持。

结果：2023年，29亿个体（95%不确定性区间2.6-3.1）受到头痛疾病影响，全球年龄标准化患病率为34.6%（31.6-37.5），YLD率为541.9（373.4-739.9）每10万人口，其中487.5（323.0-678.8）每10万人口归因于偏头痛。过去三十年中这些头痛疾病的患病率保持稳定。头痛疾病导致的YLD率在女性中（739.9[511.2-1011.5]每10万人口）是男性（346.1[240.4-481.8]每10万人口）的两倍多。药物过度使用性头痛在男性中贡献了紧张型头痛YLD估计的58.9%，在女性中贡献了56.1%，同时也贡献了男性偏头痛YLD估计的22.6%和女性的14.1%。

解释：头痛疾病，特别是偏头痛，继续是全球主要健康挑战，强调了对有效管理和预防策略的需求。通过避免过度使用药物（包括非处方药），许多头痛所致负担可以被避免或消除，这凸显了公众教育的重要性。

资助：盖茨基金会。

### 第二部分 AI 大师评价

这项基于GBD 2023的大规模系统分析全面评估了头痛疾病的全球负担，采用了创新的分层贝叶斯元回归方法和首次纳入的个体参与者数据分析，显著提升了估算精度。研究发现头痛疾病影响全球29亿人且性别差异显著，特别是药物过度使用对头痛负担的突出贡献，为公共卫生干预提供了重要依据。该研究的创新性在于将药物过度使用性头痛负担重新归因分析，并首次应用症状状态时间估算，其结果对指导全球头痛预防和治疗策略具有重要临床价值，尽管横断面数据的局限性可能影响因果推断。

---

## 4. 新生儿深部髓静脉血栓的影像学严重程度与神经发育损伤相关

**原文链接：** [https://pubmed.ncbi.nlm.nih.gov/40783051](https://pubmed.ncbi.nlm.nih.gov/40783051)
**期刊：** The Journal of pediatrics
**PMID：** 40783051
**DOI：** 10.1016/j.jpeds.2025.114769

### 第一部分 原文与翻译

**英文原标题：** Radiographic Severity of Neonatal Deep Medullary Venous Thrombosis is Associated with Neurodevelopmental Impairment.

**英文摘要原文：**
OBJECTIVE: To evaluate the association between severity of brain magnetic resonance imaging (MRI) findings and neurodevelopmental impairment (NDI) among neonates with radiographically identified deep medullary vein thrombosis (DMVT) and to develop an MRI grading system to help predict clinical outcomes.

STUDY DESIGN: We conducted a retrospective cohort study of infants admitted to a single, tertiary care hospital and diagnosed as having DMVT identified by brain MRI from January 1990 to March 2023. Clinical characteristics, MRI features, and neurodevelopmental assessments were analyzed. An MRI grading system was created to categorize the severity of radiographic injury as mild, moderate, or severe.

RESULTS: Among 63 neonates diagnosed with DMVT, 41 exhibited moderate to severe MRI lesions. These patients were more likely to experience NDI than those with mild lesions (adjusted OR 24.3, 95% CI 4.7-180.2, P < .001). Follow-up data were available for 52 infants, of whom 40.4% developed NDI. MRI severity emerged as the strongest predictor of impaired outcomes, independent of other clinical factors such as gestational age, Apgar score, or seizures at presentation.

CONCLUSIONS: Neonates with moderate or severe DMVT on MRI are at risk for NDI. The proposed MRI grading system may be a valuable classification and prognostication tool for clinicians and researchers managing DMVT in neonates.

**中文摘要译文：**
目的：评估影像学确诊的深部髓静脉血栓（DMVT）新生儿脑部磁共振成像（MRI）表现的严重程度与神经发育损伤（NDI）之间的关联，并开发一种MRI分级系统以帮助预测临床结局。

研究设计：我们对1990年1月至2023年3月期间收治于单一三级医院并经脑部MRI确诊为DMVT的婴儿进行了一项回顾性队列研究。分析了临床特征、MRI特征和神经发育评估结果。建立了一个MRI分级系统，将影像学损伤的严重程度分类为轻度、中度或重度。

结果：在63例确诊为DMVT的新生儿中，41例表现为中度至重度MRI病变。这些患者相比轻度病变患者更容易出现NDI（校正后OR 24.3, 95% CI 4.7-180.2, P < .001）。52例婴儿有随访数据，其中40.4%出现了NDI。MRI严重程度成为预后不良的最强预测因子，独立于其他临床因素，如胎龄、Apgar评分或发病时抽搐情况。

结论：MRI显示中度或重度DMVT的新生儿存在NDI风险。所提出的MRI分级系统可能成为临床医生和研究人员管理新生儿DMVT的有价值分类和预后判断工具。

### 第二部分 AI 大师评价

本研究通过回顾性队列研究探索了新生儿深部髓静脉血栓MRI影像学严重程度与神经发育损伤的关联，并创新性地开发了MRI分级系统。研究发现中度至重度MRI病变患者发生NDI的风险显著增加（OR 24.3），且MRI严重程度是独立于传统临床因素的最强预后预测因子。虽然研究受限于回顾性设计和单中心样本（63例），但建立的MRI分级系统为临床预后评估提供了重要工具，有望改善新生儿DMVT的风险分层和个体化治疗策略。

---

速递结束，祝您工作愉快！